Video Latest - ecancer

Identifying myeloid-driven biologies

Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA

28 Apr 2016

New technology can potentially overcome CAR T-cell limitations

Dr Philip Low - Purdue University, West Lafayette, USA

27 Apr 2016

Cell of origin role in cancer stem cell and GBM phenotype

Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA

27 Apr 2016

MINDACT breast cancer clinical trial: First results and impact on future trial design

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium

27 Apr 2016

Non-coding mutations driving chronic lymphocytic leukaemia

Dr Xose Puente - University of Oviedo, Oviedo, Spain

27 Apr 2016

BSH 2016: Expert discussion on front line care in CLL

Dr George Follows and Dr Andrew Zelenetz

27 Apr 2016

Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance

Dr Marianne Ratcliffe - AstraZeneca, UK

26 Apr 2016

Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy

Dr Nicholas McGranahan - Crick Institute, London, UK

26 Apr 2016

WIN 2016: Preview of themes

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

22 Apr 2016

WIN 2016: Preview of Speakers

Dr John Mendelsohn - Chairman of the WIN Consortium

22 Apr 2016

EBMT 2016 Highlights: Expert discussion

Prof Paul Richardson and Prof Mohamad Mohty

11 Apr 2016

Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer

Prof Sine Reker Hadrup - Technical University of Denmark, Kongens Lyngby, Denmark

7 Apr 2016

Video